BMS-470539 is a synthetic small molecule drug which acts as a potent and highly selective full agonist of the MC1 receptor. It was discovered in 2003 as part of an […]
List of articles in "Drug" category - Page 53
Tynorphin
Tynorphin is a synthetic opioid peptide which is a potent and competitive inhibitor of the enkephalinase class of enzymes which break down the endogenous enkephalin peptides. It specifically inactivates dipeptidyl […]
Kelatorphan
Kelatorphan is a drug which acts as a powerful and complete inhibitor of nearly all of the enzymes responsible for catabolism of the endogenous enkephalins including neutral endopeptidase (NEP) dipeptidyl […]
Sofosbuvir
Sofosbuvir (brand name Sovaldi) is a drug used for hepatitis C infection with a high cure rate. It inhibits the RNA polymerase that the hepatitis C virus (HCV) uses to […]
PRO 2000
PRO 2000 is an experimental vaginal microbicide which has been proposed as a preventative medicine for reducing the risk of contracting HIV. It has never been recommended as an effective […]
34-Dichloroamphetamine
34-Dichloroamphetamine (DCA) is an amphetamine derived drug invented by Eli Lilly in the 1960s which has a number of pharmacological actions. It acts as a highly potent and selective serotonin […]
1-Aminomethyl-5-methoxyindane
1-Aminomethyl-5-methoxyindane (AMMI) is a drug developed by a team led by David E. Nichols at Purdue University which acts as a selective serotonin releasing agent (SSRA) and binds to the […]
RTI-83
(–)-2β-Carbomethoxy-3β-(4-ethylphenyl)tropane (RTI-83) is a phenyltropane derivative which represents a rare example of an SDRI or serotonin-dopamine reuptake inhibitor a drug which inhibits the reuptake of the neurotransmitters serotonin and dopamine […]
Lapisteride
Lapisteride (INN; CS-891) is a dual inhibitor of both isoforms of the enzyme 5α-reductase. It was under investigation for the treatment of benign prostatic hyperplasia (BPH) and androgenic alopecia but […]
Semuloparin sodium
Semuloparin (INN USAN) is an experimental antithrombotic being developed by Sanofi-Aventis and belongs to the group of low molecular weight heparins (LMWH). It has completed Phase III clinical trials for […]